Highlights
- Sales over the Year and quarter: The company experienced a substantial growth of 18.06 % in the past year, substantial increase in net sales/revenue by 24.15 %.
- Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 19.43 %. Marginal decrease of -16.84% in other income during this quarter.
- Profit over the Year and quarter: Significant improvement in profitability for Divi’s Laboratories Ltd.. Notable increase of 67.62 % in net profit Year to Year, Divi’s Laboratories Ltd.’s profitability increased by 50.28 % in this quarter.
- EPS over the Year and quarter: EPS increased by 67.49 % Year to Year. EPS increased by 50 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 1950.77 Cr | Rs. 1855 Cr | Rs. 2303 Cr | + 24.15 % | + 18.06 % |
| Expenses | Rs. 1463.18 Cr | Rs. 1366 Cr | Rs. 1572 Cr | + 15.08 % | + 7.44 % |
| Operating Profit | Rs. 487.59 Cr | Rs. 489 Cr | Rs. 731 Cr | + 49.49 % | + 49.92 % |
| OPM % | 24.99 % | 26.36 % | 31.74 % | + 5.38 % | + 6.75 % |
| Other Income | Rs. 66.15 Cr | Rs. 95 Cr | Rs. 79 Cr | -16.84 % | + 19.43 % |
| Interest | Rs. 0.24 Cr | Rs. 0 Cr | Rs. 2 Cr | 0 % | + 733.33 % |
| Depreciation | Rs. 87.02 Cr | Rs. 95 Cr | Rs. 95 Cr | + 0 % | + 9.17 % |
| Profit before tax | Rs. 466.48 Cr | Rs. 489 Cr | Rs. 713 Cr | + 45.81 % | + 52.85 % |
| Tax % | 31.19 % | 26.79 % | 24.54 % | -2.25 % | -6.65 % |
| Net Profit | Rs. 320.97 Cr | Rs. 358 Cr | Rs. 538 Cr | + 50.28 % | + 67.62 % |
| EPS in Rs | Rs. 12.09 | Rs. 13.5 | Rs. 20.25 | + 50 % | + 67.49 % |
Today, we’re looking at Divi’s Laboratories Ltd.’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 18.06 %. However, it did see a marginal increase of 24.15 % from the previous quarter. Expenses ticked up slightly by 15.08 % quarter-on-quarter, aligning with the annual rise of 7.44 %. Operating profit, while up 49.92 % compared to last year, faced a quarter-on-quarter increase of 49.49 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 6.75 %, but an expansion of 5.38 % sequentially. Other income fell by -16.84 % compared to the last quarter, despite an annual growth of 19.43 %. yet the year-over-year increase remains at a moderate 733.33 %. Depreciation costs climbed by 0 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 9.17 %. Profit before tax grew annually by 52.85 % but saw an increase from the preceding quarter by 45.81 %.
Tax expenses as a percentage of profits decreased slightly by -6.65 % compared to last year, with a more notable quarter-on-quarter decrease of -2.25 %. Net profit rose by 67.62 % year-on-year but experienced a 50.28 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 67.49 % but a quarterly rise of 50 %. In summary, Divi’s Laboratories Ltd.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 1950.77 Cr | Rs. 1855 Cr | Rs. 2303 Cr | + 24.15 % | + 18.06 % |
| Expenses | Rs. 1463.18 Cr | Rs. 1366 Cr | Rs. 1572 Cr | + 15.08 % | + 7.44 % |
| Operating Profit | Rs. 487.59 Cr | Rs. 489 Cr | Rs. 731 Cr | + 49.49 % | + 49.92 % |
| Net Profit | Rs. 320.97 Cr | Rs. 358 Cr | Rs. 538 Cr | + 50.28 % | + 67.62 % |
| EPS in Rs | Rs. 12.09 | Rs. 13.5 | Rs. 20.25 | + 50 % | + 67.49 % |
In reviewing Divi’s Laboratories Ltd.’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 18.06 % year-on-year growth, however, there was a minor increase of 24.15 % from the previous quarter. Expenses rose by 7.44 % compared to the previous year, with a 15.08 % increase quarter-on-quarter. Operating Profit surged by 49.92 % annually, and saw a 49.49 % increase from the last quarter.
Net Profit showed yearly increase of 67.62 %, and experienced a 50.28 % increase from the previous quarter. Earnings Per Share (EPS) rose by 67.49 % annually, however rose by 50 % compared to the last quarter. In essence, while Divi’s Laboratories Ltd. exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
